PUNE, 30 August 2022 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Report, of Global ablation technology market is expected to clock US$18.09 billion by 2030 grow at a CAGR of 8.9% during the forecast period. This is due to the rising prevalence of cardiovascular disease and the availability of technologically advanced products and increasing demand for minimally invasive surgery. This exclusive information is published by Growth Plus Reports in a report titled “Ablation.” technology market – Global outlook and forecast period 2022-2030”
Request a sample copy of our research report: https://growthplusreports.com/inquiry/request-sample/ablation-technology-market/7776
market driver
Rising prevalence of cancer and cardiovascular disease (CVD), and growing geriatric population are major growth factors for the global ablation market. Benefits such as faster recovery, lower risk of infection compared to traditional surgery, shorter hospital stays, less discomfort, and smaller incisions have increased the demand for minimally or non-invasive procedures. The commercial introduction of new generation technologies is also paving the way for market growth. For example, in January 2021, Medtronic Inc. received FDA approval for its DiamondTempTM ablation catheter for the treatment of arrhythmias. The device has an improved imaging system that is more portable and more accurate.
The global ablation technology market is analyzed from four perspectives: products, applications, end users and regions.
excerpt from “Product Segmentation”
Based on product type, the global ablation technology market is segmented into:
- radio frequency
- cryoablation
- laser
- ultrasound
- microwave
- Electricity
- hot water
The radiofrequency segment will dominate the global market with the largest market share in 2021, followed by cryoablation. Over the last few years, there has been a growing trend toward using radiofrequency ablation technology to treat a vast array of ailments, including heart disease, cancer, chronic pain, and eye disease. Similarly, cryoablation can be used to detect skin abnormalities, atypical moles, warts, skin tags, actinic keratosis (precancerous skin growths), arrhythmias (abnormal heart rate and rhythm), and cancer tumors (skin, liver, kidney, bone, lung, prostate, breast).
excerpt from Application segmentation
Based on application, the global ablation technology market is segmented into:
- cancer treatment
- cardiovascular therapy
- gynecological treatment
- cosmetic surgery
- pain management
- Ophthalmology
- Urology
- orthopedics
- others
The cardiovascular segment dominated the market with the largest market share in 2021. Cancer therapy is another prominent application area for ablation technology. According to the American Cancer Society, there will be 1.9 million new cancer cases in the United States in 2021 and 608,57 cancer deaths. Several solid tumors are increasingly being treated with ablative procedures that have proven to be more effective and safe. Therefore, the demand for safe and efficient techniques for cancer treatment and growing awareness of ablation procedures are expected to boost the growth of this segment.
Get a customized report as per your requirements. https://growthplusreports.com/inquiry/customization/ablation-technology-market/7776
Excerpt from “By Region Segmentation”
Based on region, the global ablation technology market is segmented as follows:
- North America
- Europe
- Asia Pacific
- rest of the world
North America will dominate the global ablation technology market in 2021, followed by Europe. The Asia-Pacific market is expected to grow at the fastest he CAGR during the forecast period. North America’s large share of the global ablation technology market can be attributed to high demand for non-invasive or minimally invasive procedures and increasing prevalence of cancer and cardiovascular disease. The region has a high level of awareness of ablation technology, the presence of a developed medical infrastructure, high medical costs, and rapid adoption of new treatments. For example, in 2019 the US FDA approved his TactiCath contact force ablation catheter by Abbott Laboratories for the treatment of atrial fibrillation. Growth in the Asia-Pacific region can be attributed to rising prevalence of cardiovascular disease and cancer, but government initiatives in the region are increasing awareness of ablation techniques. is also a major growth driver. According to the WHO, in Southeast Asia in 2017 he was 9.8% of the population over the age of 60 and is estimated to increase by 13.7% in 2030 and reach 20.3% in 2050.
Excerpt from “Competitive Landscape”
Some of the prominent players operating in the global Ablation Technology market are:
- medtronic plc
- Angio Dynamics Inc.
- Abbott Laboratories, Inc.
- Boston Scientific Corporation
- Johnson & Johnson (Ethicon)
- Conmed Co., Ltd.
- Bausch & Lomb
- Biotronik SE & Co. KG
- Atricure Co., Ltd.
- Varian Medical Systems
- Olympus Corporation
- Dornier Medtech
- above all
table of contents:
- Foreword
- market ecosystem
- timeline under consideration
- Historic year – 2020
- Base Year – 2021
- Forecast Years – 2022 to 2030
- Currency used in reports
- research method
- research approach
- Data collection method
- data source
- secondary source
- primary source
- Market estimation approach
- bottom up
- top down
- Market forecast model
- Limitations and Assumptions
- Premium Insight
- Current Market Trends (COVID-19 Perspective)
- Key Players and Competitive Positioning (2021)
- market dynamics
- driver
- restraint/challenge
- chance
- Global Ablation Technology Market – Analysis and Forecast by Product
- radio frequency
- cryoablation
- laser
- ultrasound
- microwave
- Electricity
- hot water
- Global Ablation Technology Market – Analysis and Forecast by Application
- cancer
- cardiovascular
- Gynecology
- cosmetic
- pain management
- Ophthalmology
- Urology
- orthopedics
- others
- Global Ablation Technology Market – Analysis and Forecast, By End User
- hospital
- Ambulatory Surgery Center
- medical spa
- others
TOC continued…
Value proposition related to the report:
- Featuring free analyst time and expert interviews for each report
- Comprehensive quantitative and qualitative insights at segment and subsegment level
- Covid 19 impact trends and outlook
- Detailed insights at global/regional/country level
- Deep insight into market dynamics (drivers, constraints, opportunities) and business environment
- Comprehensive coverage of the competitive environment
- victory conditions
- Exhaustive coverage on “strategic developments” registered by key players in the market
Customization options:
- Distributor Landscape Assessment
- price intelligence
- Customer base evaluation
- Analysis of investments and initiatives
- “Business Profiles” of Key Players
Talk to our experts: https://growthplusreports.com/inquiry/speak-analyst/ablation-technology-market/7776
about us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge services company. We are proud to be members of the EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus’ portfolio of services leverages core capabilities such as secondary and primary research, market modeling and forecasting, benchmarking, analytics, and strategy development to create scalable, breakthrough solutions that prepare clients for future growth and success. We will help you to do so.
We have been honored as “Most Innovative Healthcare Market Research Firm in 2020” by the prestigious CEO Magazine.
.
